Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva
The design of clinical trials in rare diseases is often complicated by a lack of real-world translational knowledge. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder characterized ...